Shenzhen Salubris Pharmaceuticals Co. Ltd Archives

1 minute read

SalubrisBio Secures $35M for Biologic Therapeutics Development

Key Highlights $35 million capital infusion to support SalubrisBio’s ongoing R&D in novel biologic therapeutics. Updates on clinical programs…

April 24, 2024